AU2001236909A1 - Method of treating disorders of the eye - Google Patents

Method of treating disorders of the eye

Info

Publication number
AU2001236909A1
AU2001236909A1 AU2001236909A AU3690901A AU2001236909A1 AU 2001236909 A1 AU2001236909 A1 AU 2001236909A1 AU 2001236909 A AU2001236909 A AU 2001236909A AU 3690901 A AU3690901 A AU 3690901A AU 2001236909 A1 AU2001236909 A1 AU 2001236909A1
Authority
AU
Australia
Prior art keywords
eye
treating disorders
disorders
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001236909A
Inventor
David Esptein
Janardan Kumar
Vasanth Rao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Duke University
Original Assignee
Duke University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duke University filed Critical Duke University
Publication of AU2001236909A1 publication Critical patent/AU2001236909A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70546—Integrin superfamily, e.g. VLAs, leuCAM, GPIIb/GPIIIa, LPAM
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
AU2001236909A 2000-02-11 2001-02-12 Method of treating disorders of the eye Abandoned AU2001236909A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18186900P 2000-02-11 2000-02-11
US60/181,869 2000-02-11
PCT/US2001/004437 WO2001058931A1 (en) 2000-02-11 2001-02-12 Method of treating disorders of the eye

Publications (1)

Publication Number Publication Date
AU2001236909A1 true AU2001236909A1 (en) 2001-08-20

Family

ID=22666147

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001236909A Abandoned AU2001236909A1 (en) 2000-02-11 2001-02-12 Method of treating disorders of the eye

Country Status (4)

Country Link
US (1) US20010053766A1 (en)
EP (1) EP1257566A4 (en)
AU (1) AU2001236909A1 (en)
WO (1) WO2001058931A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1551399A4 (en) * 2002-09-30 2011-01-05 Mark A Babizhayev Method for topical treatment of eye disease and composition and device for said treatment
US20040167076A1 (en) * 2003-02-14 2004-08-26 Stamer W. Daniel Modulation of aqueous humor outflow by targeting vascular-endothelial-cadherin in schlemm's canal cells

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5041450A (en) * 1988-06-29 1991-08-20 Research Corporation Technologies, Inc. Treatment of ocular inflammation
US5683867A (en) * 1990-06-11 1997-11-04 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: blended SELEX
ATE179074T1 (en) * 1991-11-07 1999-05-15 Univ Southern California COMPOSITIONS AND METHODS FOR PREVENTING ADHESION FORMATION
US5536814A (en) * 1993-09-27 1996-07-16 La Jolla Cancer Research Foundation Integrin-binding peptides
US5753230A (en) * 1994-03-18 1998-05-19 The Scripps Research Institute Methods and compositions useful for inhibition of angiogenesis
DE19534016A1 (en) * 1995-09-14 1997-03-20 Merck Patent Gmbh Biotin derivatives
JPH1017488A (en) * 1996-06-25 1998-01-20 Asahi Glass Co Ltd Glaucoma treating agent
US5900414A (en) * 1996-08-29 1999-05-04 Merck & Co., Inc. Methods for administering integrin receptor antagonists

Also Published As

Publication number Publication date
EP1257566A4 (en) 2005-06-15
US20010053766A1 (en) 2001-12-20
WO2001058931A9 (en) 2002-10-17
EP1257566A1 (en) 2002-11-20
WO2001058931A1 (en) 2001-08-16

Similar Documents

Publication Publication Date Title
AU2001269799A1 (en) Methods for treating various eye disorders
AU2001249881A1 (en) Method of treating the heart
AU7316601A (en) Methods for treating inflammation-mediated conditions of the eye
AU2001288628A1 (en) Method and reagents for treatment of skin disorders by modulating the notch pathway
AU2002215125A1 (en) Well treatment method
AU2003210597A1 (en) Methods for treating eye disorders
AU2001294794A1 (en) Method and apparatus for spectrophotometry of the eye
AU3977700A (en) Method of treating neurological disorders
AU2001286983A1 (en) Method of treatment
ZA200003768B (en) Methods and compositions for treating diseases and conditions of the eye.
AU2001237939A1 (en) Methods for treating glaucoma
MXPA03003741A (en) Methods and compositions for the treatment of diseases of the eye.
AU4552200A (en) Method of treating psychotic disorders
AU2002241670A1 (en) Method for treating glaucoma IB
AU2001288792A1 (en) Method of treating neurologic disorders
AU3757300A (en) Method of treating anxiety disorders
AU2002320352A1 (en) Methods for treating or preventing sclerotic disorders using cd2-binding agents
AU1133901A (en) Method of treating metabolic disorders
AU2002258798A1 (en) Methods for the treatment of hepatic disorders
AU2001292705A1 (en) Method of treating gastrointestinal disorders, particularly colitis
AU2001262177A1 (en) Method of treatment
AU2001236909A1 (en) Method of treating disorders of the eye
AU3753500A (en) Methods of treating fibrinogen-related disorders
PL367097A1 (en) Method of treating dry eye disorders
AU2002229795A1 (en) Method for treating sexual disorders